Intactis Bio

Intactis Bio consists of a proprietary neural tissue, brain machine interface, and biocomputation platform.

Health and bio

Intactis Bio has no funding amount on record yet; its latest known round is Seed (Feb 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• DR
  Daniel Rodriguez Founder

  source: crunchbase.com

Raise history

1. February 24, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related other companies

• SSharp$328K · Oct 1, 2026
• OOptimizeGEO.ai$80M · Oct 1, 2026
• WWedding WeekenderOct 1, 2026
• RR2CreteOct 1, 2026
• FFoundational$8.2M · Oct 1, 2026
• SSubvocal$1.3M · Sep 30, 2026
• GGravity Design$15M · Sep 30, 2026
• AAdaptCloseSep 30, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/intactis-bio.